mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.1 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.1 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.1 |
mRNA |
BIBR-1532 |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.1 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.1 |
mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.1 |